Literature DB >> 31899311

SUR1-TRPM4 channels, not KATP, mediate brain swelling following cerebral ischemia.

Seung Kyoon Woo1, Natalia Tsymbalyuk1, Orest Tsymbalyuk1, Svetlana Ivanova1, Volodymyr Gerzanich1, J Marc Simard2.   

Abstract

BACKGROUND: Preclinical and emerging clinical data show that glibenclamide reduces space occupying edema and brain swelling following cerebral ischemia. Glibenclamide is a potent inhibitor of numerous sulfonylurea receptor (SUR)-regulated channels, including KATP (SUR1-KIR6.2, SUR2A-KIR6.2, SUR2B-KIR6.2, SUR2B-KIR6.1) and SUR1-TRPM4. Here, we used molecularly specific oligodeoxynucleotides (ODNs) to investigate the role of various SUR-regulated ion channel subunits in post-ischemic brain swelling.
METHODS: Focal cerebral ischemia was induced in adult male rats by permanent middle cerebral artery occlusion (pMCAo). We used this model to study the effects of antisense-ODNs (AS-ODNs) directed against Abcc8/SUR1, Trpm4/TRPM4, Kcnj8/KIR6.1 and Kcnj11/KIR6.2 on hemispheric swelling, with sense or scrambled ODNs used as controls. We used antibody-based Förster resonance energy transfer (immuno-FRET) and co-immunoprecipitation to study the co-assembly of SUR1-TRPM4 heteromers.
RESULTS: In the combined control groups administered sense or scrambled ODNs, pMCAo resulted in uniformly large infarct volumes (mean ± SD: 57.4 ± 8.8 %; n = 34) at 24 h after onset of ischemia, with no effect of AS-ODNs on infarct size. In controls, hemispheric swelling was 23.9 ± 4.1 % (n = 34), and swelling was linearly related to infarct volume (P < 0.02). In the groups administered anti-Abcc8/SUR1 or anti-Trpm4/TRPM4 AS-ODN, hemispheric swelling was significantly less, 11.6 ± 3.9 % and 12.8 ± 5.8 % respectively (P < 0.0001), and the relationship between infarct volume and swelling was reduced and not significant. AS-ODNs directed against Kcnj8/KIR6.1 and Kcnj11/KIR6.2 had no significant effect on hemispheric swelling (23.3 ± 5.4 % and 22.9 ± 5.8 % respectively). Post-ischemic tissues showed co-assembly of SUR1-TRPM4 heteromers.
CONCLUSIONS: Post-ischemic hemispheric swelling can be decoupled from infarct volume. SUR1-TRPM4 channels, not KATP, mediate post-ischemic brain swelling.
Copyright © 2019 The Author(s). Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cerebral edema; Cerebral ischemia; Hemispheric swelling; K(ATP) channel; SUR1-TRPM4 channel; Sulfonylurea receptor 1 (SUR1); Transient receptor potential melastatin 4 (TRPM4)

Mesh:

Substances:

Year:  2019        PMID: 31899311      PMCID: PMC6981040          DOI: 10.1016/j.neulet.2019.134729

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  44 in total

1.  Brain edema predicts outcome after nonlacunar ischemic stroke.

Authors:  Thomas W K Battey; Mahima Karki; Aneesh B Singhal; Ona Wu; Saloomeh Sadaghiani; Bruce C V Campbell; Stephen M Davis; Geoffrey A Donnan; Kevin N Sheth; W Taylor Kimberly
Journal:  Stroke       Date:  2014-10-21       Impact factor: 7.914

Review 2.  Physiology and pathophysiology of K(ATP) channels in the pancreas and cardiovascular system: a review.

Authors:  Susumu Seino
Journal:  J Diabetes Complications       Date:  2003 Mar-Apr       Impact factor: 2.852

3.  Glibenclamide enhances neurogenesis and improves long-term functional recovery after transient focal cerebral ischemia.

Authors:  Francisco J Ortega; Jukka Jolkkonen; Nicole Mahy; Manuel J Rodríguez
Journal:  J Cereb Blood Flow Metab       Date:  2012-11-14       Impact factor: 6.200

4.  Glibenclamide ameliorates ischemia-reperfusion injury via modulating oxidative stress and inflammatory mediators in the rat hippocampus.

Authors:  Dalaal M Abdallah; Noha N Nassar; Rania M Abd-El-Salam
Journal:  Brain Res       Date:  2011-03-05       Impact factor: 3.252

5.  Glibenclamide is superior to decompressive craniectomy in a rat model of malignant stroke.

Authors:  J Marc Simard; Natalia Tsymbalyuk; Orest Tsymbalyuk; Svetlana Ivanova; Vladimir Yurovsky; Volodymyr Gerzanich
Journal:  Stroke       Date:  2010-01-21       Impact factor: 7.914

6.  Newly expressed SUR1-regulated NC(Ca-ATP) channel mediates cerebral edema after ischemic stroke.

Authors:  J Marc Simard; Mingkui Chen; Kirill V Tarasov; Sergei Bhatta; Svetlana Ivanova; Ludmila Melnitchenko; Natalya Tsymbalyuk; G Alexander West; Volodymyr Gerzanich
Journal:  Nat Med       Date:  2006-03-19       Impact factor: 53.440

7.  Glibenclamide-10-h Treatment Window in a Clinically Relevant Model of Stroke.

Authors:  J Marc Simard; Seung Kyoon Woo; Natalia Tsymbalyuk; Oksana Voloshyn; Vladimir Yurovsky; Svetlana Ivanova; Ryan Lee; Volodymyr Gerzanich
Journal:  Transl Stroke Res       Date:  2012-03-07       Impact factor: 6.829

8.  Effect of IV glyburide on adjudicated edema endpoints in the GAMES-RP Trial.

Authors:  W Taylor Kimberly; Matthew B Bevers; Rüdiger von Kummer; Andrew M Demchuk; Javier M Romero; Jordan J Elm; Holly E Hinson; Bradley J Molyneaux; J Marc Simard; Kevin N Sheth
Journal:  Neurology       Date:  2018-11-16       Impact factor: 9.910

9.  The sulfonylurea receptor 1 (Sur1)-transient receptor potential melastatin 4 (Trpm4) channel.

Authors:  Seung Kyoon Woo; Min Seong Kwon; Alexander Ivanov; Volodymyr Gerzanich; J Marc Simard
Journal:  J Biol Chem       Date:  2012-12-19       Impact factor: 5.157

10.  Glibenclamide Administration Attenuates Infarct Volume, Hemispheric Swelling, and Functional Impairments following Permanent Focal Cerebral Ischemia in Rats.

Authors:  Bushra Wali; Tauheed Ishrat; Fahim Atif; Fang Hua; Donald G Stein; Iqbal Sayeed
Journal:  Stroke Res Treat       Date:  2012-09-04
View more
  6 in total

Review 1.  Emerging therapeutic targets for cerebral edema.

Authors:  Ruchira M Jha; Sudhanshu P Raikwar; Sandra Mihaljevic; Amanda M Casabella; Joshua S Catapano; Anupama Rani; Shashvat Desai; Volodymyr Gerzanich; J Marc Simard
Journal:  Expert Opin Ther Targets       Date:  2022-01-02       Impact factor: 6.797

Review 2.  TRPM3 in Brain (Patho)Physiology.

Authors:  Katharina Held; Balázs István Tóth
Journal:  Front Cell Dev Biol       Date:  2021-02-26

Review 3.  Specificity Protein 1: A Protein With a Two-Sided Role in Ischemic Stroke.

Authors:  Qinyang Yu; Wangyang Liu; Zhuohui Chen; Mengqi Zhang
Journal:  Front Cell Neurosci       Date:  2021-12-14       Impact factor: 5.505

4.  Emergent Temporal Signaling in Human Trabecular Meshwork Cells: Role of TRPV4-TRPM4 Interactions.

Authors:  Oleg Yarishkin; Tam T T Phuong; Felix Vazquez-Chona; Jacques Bertrand; Joseph van Battenburg-Sherwood; Sarah N Redmon; Christopher N Rudzitis; Monika Lakk; Jackson M Baumann; Marc Freichel; Eun-Mi Hwang; Darryl Overby; David Križaj
Journal:  Front Immunol       Date:  2022-03-31       Impact factor: 7.561

5.  Drug development in targeting ion channels for brain edema.

Authors:  Zheng-Wei Luo; Andrea Ovcjak; Raymond Wong; Bao-Xue Yang; Zhong-Ping Feng; Hong-Shuo Sun
Journal:  Acta Pharmacol Sin       Date:  2020-08-27       Impact factor: 6.150

Review 6.  Pharmacological Modulation and (Patho)Physiological Roles of TRPM4 Channel-Part 2: TRPM4 in Health and Disease.

Authors:  Csaba Dienes; Zsigmond Máté Kovács; Tamás Hézső; János Almássy; János Magyar; Tamás Bányász; Péter P Nánási; Balázs Horváth; Norbert Szentandrássy
Journal:  Pharmaceuticals (Basel)       Date:  2021-12-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.